End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
5-day change
1st Jan Change
21,950
KRW
+1.62%
0.00%
-7.19%
Huons Global Co., Ltd.'s Equity Buyback announced on March 16, 2022, has expired with 162,128 shares, representing 1.31% for KRW 4,993.95 million.
The company expired its plan on September 16, 2022.
Huons Global Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
03-20
CI
Huons Global Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Huons Global Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/08/23
CI
Huons Global Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/05/23
CI
Huons Global Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/11/22
CI
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
16/09/22
CI
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
16/09/22
CI
Huons Global Co., Ltd.'s Equity Buyback announced on March 16, 2022, has expired with 162,128 shares, representing 1.31% for KRW 4,993.95 million.
15/09/22
CI
Huons Global Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
16/08/22
CI
HuM&C Co., Ltd. acquired 75.32% of stake in Hubena Co., Ltd. from HunoLab and Huons Global Co., Ltd. for KRW 28,501.2.
14/07/22
CI
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
17/06/22
CI
Huons Global Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
16/05/22
CI
Huons Global Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
23/03/22
CI
Huons Global Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
16/03/22
CI
Huons Global Co., Ltd. authorizes a Buyback Plan.
15/03/22
CI
Huons Global Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
15/11/21
CI
Huons Global Co., Ltd. announced that it has received KRW 50 billion in funding
31/10/21
CI
Huons Global Co., Ltd. announced that it expects to receive KRW 50 billion in funding
27/10/21
CI
Huons Global : South Korean consortium to produce Russia's Sputnik Light vaccine
28/06/21
RE
Imeik Technology Development Co.,Ltd. signed a contract to acquire a 10.5% stake of Huons Bio Pharma Co.,Ltd. from Huons Global Co., Ltd. for KRW 53.5 billion.
23/06/21
CI
Huons Global : S.Korean consortium to produce 100 mln doses a month of Russia's Sputnik V vaccine
16/04/21
RE
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
23/02/21
CI
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
23/02/21
CI
Huons Global Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 133,523 shares, representing 1.12% for KRW 3,990.62 million.
17/02/21
CI
Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
23/11/20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Huons Global Co., Ltd., formerly, Huons Co., Ltd. is Kore-based entity principally engaged in the manufacture and distribution of pharmaceutical products. Along with its subsidiaries, the Company operates its business through two segments: pharmaceutical segment and glass container segment. The pharmaceutical segment produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermines, diet pills and others; capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. The glass container segment produces ampoules, vials, cartridges and caps for used of medicals, foods and cosmetics. The Company also manufactures medical devices such as kits, derma injectors and other injector.
More about the company
1st Jan change
Capi.
-7.19% 199M +14.85% 78.37B +11.98% 9.08B -12.85% 5.06B +54.35% 4.85B +15.78% 2.37B -20.85% 2.36B +24.62% 2.27B -29.25% 2.22B -0.50% 1.64B
Specialty & Advanced Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1